Filing excerpt
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs (in millions, except share and per share data) ... $5,337
sec.gov/Archives/edgar/data/1156039/000115603926000060/elv-20260630.htmRead the full source
Elevance Health10-Q: Capex increase
Holds $5.34B remaining for share repurchases, signaling strong cash position and budget availability.
What happened
The company has a significant share repurchase program, having spent $234M in Q2 and with $5.34B still authorized as of June 2026.
Source
Other signals in this filing (5)
- Competitor namedElevance flags risk of non-compliance in pharmacy agreement with competitor Caremark (CVS Health).Competitor named
- Supply chain disruptionElevance flags risk of non-compliance in its pharmacy services agreement with CaremarkPCS Health.Supply chain disruption
- Supplier concentrationFlags risk of non-compliance in critical pharmacy services agreement with CaremarkPCS Health.Supplier concentration
- Regulatory investigationFaces potential sanctions from Centers for Medicare & Medicaid Services (CMS) over threatened litigation.Regulatory investigation
- Market expansionElevance Health has a $5B credit line and unlimited shelf registration for acquisitions and expansion.Market expansion
Extracted by Autobound
From the Signal API record- Signal
- 10-Q: Capex increase
What this signalsFilings often name leadership changes, deals and spending plans.
- Fiscal year end
- 06/30
- Filed
- Jul 15, 2026
More from Elevance Health
- PatentsElevance Health, Inc.'s patent output is slowing: 11 grants in the past year, 0 in the past 30 days.Patents
- LayoffFierce Healthcare Layoff Tracker - PeaceHealth cuts 150; Elevance Health eliminates 216 in LouisianaLayoff
- 8-KElevance Health flags risk of non-compliance in material pharmacy services agreement with CaremarkPCS Health8-K
- GlassdoorSignificant employee turnover with half of staff leaving in six monthsGlassdoor
- NewsElevance Health’s CEO started her career as a pro basketball player. Now she’s the highest‑ranking woman on the Global 500, leading a $199B giantNews
- EarningsElevance shuts down D.C. Medicaid business, eyes additional exits after passable Q2Earnings
More 10-Q signals at other companies
- SEC 10-QMillerKnoll, Inc.Jeffrey M. Stutz appointed Interim Chief Executive Officer.SEC 10-Q
- SEC 10-QCID HoldCo, Inc.Disclosed material weaknesses in financial reporting due to insufficient accounting staff and controls.SEC 10-Q
- SEC 10-QScholastic CorporationCore school channels decline with fewer book fairs and lower club participation.SEC 10-Q
The full record
From the Signal API recordNumbers
- Dollar figure
- $5.3B (Remaining authorization for share repurchase program)
Details
- CIK
- 1156039
- Accession number
- 0001156039-26-000060
- Filing year
- 2026
- Fiscal year
- 0
- Why it matters
- Budget available
- Signal category
- Financial
Extraction
- Confidence
- High
- Relevance
- 70%
- Sentiment
- Positive
- Detected
- Jul 21, 2026
- signal_type
sec-10q- signal_subtype
capexIncrease
Use this data
Get every 10-Q signal for Elevance Health and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Elevance Health this week?”
Send it to your own tools
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/b3058261-009f-4d14-84a1-b291784c362b returns this record as JSON. POST /v1/companies/enrich returns every signal for elevancehealth.com.
{
"signal_id": "b3058261-009f-4d14-84a1-b291784c362b",
"signal_type": "sec-10q",
"signal_subtype": "capexIncrease",
"detected_at": "2026-07-21T07:03:08.505+00:00",
"company": {
"name": "Elevance Health",
"domain": "elevancehealth.com"
},
"data": {
"detail": "The company has a significant share repurchase program, having spent $234M in Q2 and with $5.34B still authorized as of June 2026. This demonstrates a very strong cash position and financial health, indicating available budget for strategic investments in technology and operations.",
"metrics": {
"dollar_context": "Remaining authorization for share repurchase program",
"dollar_millions": 5337
},
"summary": "Holds $5.34B remaining for share repurchases, signaling strong cash position and budget availability.",
"excerpts": "Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs (in millions, except share and per share data) ... $5,337",
"relevance": 0.7,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1156039/000115603926000060/elv-20260630.htm",
"filing_date": "2026-07-15",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Budget available",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/b3058261-009f-4d14-84a1-b291784c362b \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"elevancehealth.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.